Daniel Stauder
Stock Analyst at JMP Securities
(4.50)
# 522
Out of 4,944 analysts
18
Total ratings
70.59%
Success rate
16.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Market Outperform | $33 → $42 | $43.73 | -3.96% | 5 | Aug 8, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $36.73 | +63.35% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $3.87 | +80.88% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $95.15 | +15.61% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $765.52 | -5.29% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $10.75 | - | 1 | May 7, 2024 |
Artivion
Aug 8, 2025
Maintains: Market Outperform
Price Target: $33 → $42
Current: $43.73
Upside: -3.96%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $36.73
Upside: +63.35%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $3.87
Upside: +80.88%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $95.15
Upside: +15.61%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $765.52
Upside: -5.29%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $10.75
Upside: -